Diversified Trust Co Boosts Stock Holdings in Colgate-Palmolive Company $CL

Diversified Trust Co grew its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 10.2% during the first quarter, Holdings Channel reports. The institutional investor owned 102,581 shares of the company’s stock after purchasing an additional 9,465 shares during the quarter. Diversified Trust Co’s holdings in Colgate-Palmolive were worth $8,743,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the stock. Baron Wealth Management LLC increased its stake in Colgate-Palmolive by 95.9% in the 1st quarter. Baron Wealth Management LLC now owns 6,865 shares of the company’s stock worth $585,000 after purchasing an additional 3,360 shares during the period. Cornerstone Planning LLC purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $1,442,000. Rockefeller Capital Management L.P. boosted its stake in shares of Colgate-Palmolive by 6.1% during the fourth quarter. Rockefeller Capital Management L.P. now owns 182,223 shares of the company’s stock valued at $14,399,000 after purchasing an additional 10,512 shares during the period. World Investment Advisors grew its holdings in shares of Colgate-Palmolive by 102.4% in the fourth quarter. World Investment Advisors now owns 25,704 shares of the company’s stock worth $2,031,000 after purchasing an additional 13,007 shares during the last quarter. Finally, Corient Private Wealth LLC raised its holdings in Colgate-Palmolive by 13.6% during the 4th quarter. Corient Private Wealth LLC now owns 541,110 shares of the company’s stock valued at $42,789,000 after buying an additional 64,926 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.3%

Shares of NYSE CL opened at $89.74 on Friday. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The firm has a market capitalization of $71.81 billion, a PE ratio of 34.92, a price-to-earnings-growth ratio of 4.72 and a beta of 0.33. The firm has a fifty day simple moving average of $87.40 and a two-hundred day simple moving average of $86.60.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.94 by $0.03. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The company’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period last year, the company posted $0.91 EPS. Equities analysts expect that Colgate-Palmolive Company will post 3.81 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 8th. Weiss Ratings raised shares of Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $99.00 target price on shares of Colgate-Palmolive in a report on Monday, May 4th. Piper Sandler reduced their price target on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. Finally, UBS Group upped their price target on Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.